Proficio Capital Partners LLC Acquires Shares of 21,631 Prestige Consumer Healthcare Inc. (NYSE:PBH)

Proficio Capital Partners LLC acquired a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 21,631 shares of the company's stock, valued at approximately $1,689,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kestra Investment Management LLC bought a new position in Prestige Consumer Healthcare during the 4th quarter worth approximately $27,000. GAMMA Investing LLC boosted its stake in Prestige Consumer Healthcare by 18.9% during the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock worth $108,000 after acquiring an additional 220 shares during the last quarter. KBC Group NV boosted its stake in Prestige Consumer Healthcare by 28.3% during the 4th quarter. KBC Group NV now owns 2,048 shares of the company's stock worth $160,000 after acquiring an additional 452 shares during the last quarter. Blue Trust Inc. boosted its stake in Prestige Consumer Healthcare by 24.8% during the 4th quarter. Blue Trust Inc. now owns 2,190 shares of the company's stock worth $158,000 after acquiring an additional 435 shares during the last quarter. Finally, Longboard Asset Management LP bought a new position in Prestige Consumer Healthcare during the 4th quarter worth approximately $201,000. Institutional investors own 99.95% of the company's stock.

Insider Buying and Selling

In related news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Remove Ads

Analyst Ratings Changes

A number of research analysts have weighed in on PBH shares. Oppenheimer lifted their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research note on Thursday, February 13th. DA Davidson lifted their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Sidoti lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price target on the stock. in a research note on Monday, December 9th. Royal Bank of Canada lifted their price target on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a research note on Friday. Finally, Raymond James raised shares of Prestige Consumer Healthcare to a "moderate buy" rating in a research note on Thursday, December 19th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Stock Down 0.3 %

Shares of PBH stock traded down $0.24 during trading on Friday, reaching $84.12. The company's stock had a trading volume of 640,928 shares, compared to its average volume of 258,988. The business has a fifty day moving average price of $82.46 and a 200-day moving average price of $78.62. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The company has a market cap of $4.17 billion, a price-to-earnings ratio of 19.70, a price-to-earnings-growth ratio of 2.69 and a beta of 0.46. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.